Overview Applications Mechanisms Side Effects Safety Dosing History Natural? Manufacturing Chemistry Research Related

BPC-157 (Body Protection Compound-157)

A synthetic pentadecapeptide researched for cytoprotective and tissue-repair properties

Experimental Tissue Repair Healing Cytoprotection

Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids. It was first described in scientific literature in 1993 by Croatian researchers led by Dr. Predrag Sikiric. The peptide is derived from a larger protective protein compound found naturally in human gastric juice.

While the parent compound exists naturally in the stomach, BPC-157 itself is a synthetic fragment designed to be more stable and therapeutically useful. It has gained significant attention in research and athletic communities for its potential tissue-healing and protective properties, though it remains unapproved by major regulatory agencies for human therapeutic use.

⚠️ Important Notice

BPC-157 is not FDA-approved for human use. It is classified as a research chemical and experimental peptide. The information provided here is for educational purposes only and should not be considered medical advice. Always consult with a licensed healthcare professional before considering any peptide therapy.

Key Properties

🔬 Chemical Stability

BPC-157 is remarkably stable at room temperature and resistant to enzymatic degradation, maintaining biological activity even in harsh conditions like stomach acid.

💊 Bioavailability

Studies in rodent models show bioavailability through multiple administration routes: oral, subcutaneous, intramuscular, and intravenous.

🎯 Mechanism of Action

Proposed mechanisms include promoting angiogenesis, modulating nitric oxide pathways, enhancing growth factor production, and supporting tissue regeneration.

⚡ Speed of Action

Preclinical studies suggest effects may begin within hours to days, with optimal results typically observed over weeks of consistent use.

Potential Applications (Research Stage)

Based on preclinical research, BPC-157 has been investigated for various potential applications:

  • Musculoskeletal Healing: Tendon, ligament, muscle, and bone repair
  • Gastrointestinal Protection: Ulcer healing, IBD support, NSAID damage mitigation
  • Vascular Health: Blood vessel repair, angiogenesis promotion
  • Neuroprotection: Nerve regeneration, stroke recovery, traumatic brain injury
  • Inflammation Modulation: Supporting healthy inflammatory response
  • Wound Healing: Accelerated tissue repair and regeneration

Note: These applications are based on animal studies and limited human trials. Efficacy and safety in humans have not been established through large-scale clinical trials.

Current Research Status

Animal Studies

Extensive research in rodents and small mammals

Human Trials

Very limited human studies; more research needed

Safety Data

Preliminary safety studies; long-term data lacking

Regulatory Approval

Not approved by FDA, EMA, or other major agencies

Learn More About BPC-157

Explore detailed information about specific aspects of BPC-157: